Steven Feldon
Concepts (408)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Graves Ophthalmopathy | 9 | 2007 | 3 |
Why?
| Graves Disease | 22 | 1981 | 11 |
Why?
| Optic Neuropathy, Ischemic | 12 | 1997 | 3 |
Why?
| Oculomotor Muscles | 18 | 1980 | 19 |
Why?
| Orbit | 14 | 1985 | 28 |
Why?
| Vision Disorders | 8 | 1977 | 44 |
Why?
| Decompression, Surgical | 8 | 1997 | 27 |
Why?
| Strabismus | 5 | 1992 | 16 |
Why?
| Visual Fields | 11 | 1980 | 22 |
Why?
| Paranasal Sinus Diseases | 2 | 2010 | 3 |
Why?
| Visual Field Tests | 6 | 1984 | 5 |
Why?
| Ophthalmologic Surgical Procedures | 7 | 1996 | 13 |
Why?
| Eye Movements | 10 | 1977 | 29 |
Why?
| Optic Nerve Diseases | 9 | 1982 | 8 |
Why?
| Humans | 96 | 1977 | 1856 |
Why?
| Fibroblasts | 11 | 2003 | 179 |
Why?
| Expert Systems | 2 | 2004 | 5 |
Why?
| Maxillary Sinus | 3 | 1983 | 5 |
Why?
| Diplopia | 3 | 1992 | 9 |
Why?
| Visual Acuity | 18 | 1988 | 46 |
Why?
| Middle Aged | 47 | 1977 | 1161 |
Why?
| Eye | 3 | 1984 | 37 |
Why?
| Adipocytes | 4 | 2006 | 11 |
Why?
| Enophthalmos | 1 | 2011 | 3 |
Why?
| Scleroderma, Localized | 1 | 2011 | 4 |
Why?
| Optic Nerve | 6 | 1988 | 27 |
Why?
| Scleroderma, Systemic | 1 | 2011 | 13 |
Why?
| Female | 54 | 1977 | 1643 |
Why?
| Tomography, X-Ray Computed | 18 | 1980 | 321 |
Why?
| Aged | 37 | 1978 | 988 |
Why?
| Male | 54 | 1977 | 1553 |
Why?
| Radiotherapy | 2 | 2007 | 73 |
Why?
| Adipogenesis | 3 | 2006 | 9 |
Why?
| Pyrazoles | 1 | 2008 | 42 |
Why?
| Eye Diseases | 6 | 1987 | 24 |
Why?
| Adult | 39 | 1977 | 1317 |
Why?
| Cyclooxygenase 2 Inhibitors | 1 | 2008 | 45 |
Why?
| Adrenal Cortex Hormones | 2 | 1990 | 76 |
Why?
| Sulfonamides | 1 | 2008 | 74 |
Why?
| T-Lymphocytes | 3 | 2006 | 182 |
Why?
| Giant Cell Arteritis | 4 | 1982 | 8 |
Why?
| Intracranial Hypertension | 1 | 2007 | 3 |
Why?
| Vision Tests | 3 | 1985 | 14 |
Why?
| Diagnosis, Computer-Assisted | 2 | 1981 | 39 |
Why?
| Prostaglandins | 1 | 2006 | 41 |
Why?
| Alzheimer Disease | 2 | 1994 | 71 |
Why?
| Randomized Controlled Trials as Topic | 5 | 1998 | 176 |
Why?
| Motion Perception | 3 | 1978 | 21 |
Why?
| Cyclooxygenase 2 | 1 | 2006 | 77 |
Why?
| Retrospective Studies | 9 | 1988 | 653 |
Why?
| Treatment Outcome | 8 | 1995 | 661 |
Why?
| Adipose Tissue | 3 | 1985 | 80 |
Why?
| Thyroid Hormones | 1 | 2004 | 23 |
Why?
| Cell Differentiation | 5 | 2003 | 262 |
Why?
| Thyroid Diseases | 3 | 1990 | 19 |
Why?
| Retinal Degeneration | 2 | 1982 | 16 |
Why?
| Macular Degeneration | 1 | 2003 | 10 |
Why?
| Visual Pathways | 2 | 1980 | 25 |
Why?
| Certification | 1 | 2003 | 26 |
Why?
| Evoked Potentials, Visual | 1 | 2003 | 16 |
Why?
| Clinical Protocols | 1 | 2003 | 93 |
Why?
| Contrast Sensitivity | 1 | 2003 | 16 |
Why?
| Hypercholesterolemia | 2 | 1999 | 33 |
Why?
| Membrane Proteins | 1 | 2006 | 233 |
Why?
| Quality Assurance, Health Care | 1 | 2003 | 83 |
Why?
| Pituitary Neoplasms | 3 | 1983 | 25 |
Why?
| Saccades | 6 | 1977 | 19 |
Why?
| Blindness | 4 | 1977 | 22 |
Why?
| Visual Cortex | 5 | 1978 | 26 |
Why?
| Hyaluronic Acid | 2 | 2010 | 23 |
Why?
| Diabetes Complications | 3 | 1988 | 49 |
Why?
| Hearing Loss, Sensorineural | 1 | 2000 | 18 |
Why?
| Clinical Competence | 1 | 2003 | 130 |
Why?
| Aged, 80 and over | 13 | 1988 | 599 |
Why?
| Mucocele | 3 | 1983 | 7 |
Why?
| Liver Diseases | 1 | 2000 | 56 |
Why?
| Prostaglandin D2 | 3 | 2006 | 20 |
Why?
| Exophthalmos | 6 | 1978 | 9 |
Why?
| PPAR gamma | 3 | 2006 | 38 |
Why?
| Insulin Resistance | 1 | 2000 | 37 |
Why?
| Family Health | 1 | 1999 | 69 |
Why?
| Myocardial Ischemia | 1 | 1999 | 62 |
Why?
| Myopia | 2 | 1994 | 14 |
Why?
| Cats | 6 | 1970 | 71 |
Why?
| Optic Disk | 2 | 1992 | 6 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2000 | 78 |
Why?
| Choroid Diseases | 2 | 1995 | 2 |
Why?
| Brain Neoplasms | 2 | 1980 | 116 |
Why?
| Risk Factors | 6 | 1988 | 555 |
Why?
| Orbital Pseudotumor | 1 | 1996 | 1 |
Why?
| Retinal Diseases | 2 | 1984 | 22 |
Why?
| Disease Progression | 3 | 2006 | 244 |
Why?
| Obesity | 1 | 2000 | 149 |
Why?
| Clinical Trials as Topic | 3 | 2007 | 251 |
Why?
| Follow-Up Studies | 8 | 1985 | 553 |
Why?
| Child | 9 | 1982 | 749 |
Why?
| Magnetic Resonance Imaging | 7 | 1989 | 294 |
Why?
| Triamterene | 1 | 1995 | 3 |
Why?
| Hydrochlorothiazide | 1 | 1995 | 7 |
Why?
| Orbital Neoplasms | 2 | 1992 | 16 |
Why?
| Automation | 2 | 2004 | 27 |
Why?
| Orbital Diseases | 3 | 1983 | 18 |
Why?
| Adolescent | 11 | 1980 | 891 |
Why?
| Lacrimal Apparatus | 2 | 1994 | 10 |
Why?
| Ophthalmology | 3 | 1987 | 13 |
Why?
| Color Perception | 4 | 1988 | 12 |
Why?
| Lymphoma | 1 | 1996 | 96 |
Why?
| Ophthalmoplegia | 3 | 1980 | 7 |
Why?
| Lens Capsule, Crystalline | 1 | 1994 | 4 |
Why?
| Electrocoagulation | 1 | 1994 | 12 |
Why?
| Ischemia | 2 | 1988 | 65 |
Why?
| Lens, Crystalline | 1 | 1994 | 17 |
Why?
| Aging | 2 | 1990 | 275 |
Why?
| Refraction, Ocular | 1 | 1994 | 10 |
Why?
| Eyelids | 2 | 1984 | 15 |
Why?
| Indoles | 2 | 2010 | 69 |
Why?
| Severity of Illness Index | 3 | 2004 | 358 |
Why?
| Atrophy | 2 | 1982 | 41 |
Why?
| Wound Healing | 2 | 2011 | 106 |
Why?
| Multicenter Studies as Topic | 3 | 1998 | 70 |
Why?
| Infrared Rays | 3 | 1982 | 13 |
Why?
| Ligands | 3 | 2006 | 116 |
Why?
| Fluorescein Angiography | 4 | 1982 | 19 |
Why?
| Cornea | 2 | 1992 | 36 |
Why?
| Optic Atrophies, Hereditary | 1 | 1992 | 2 |
Why?
| Felty's Syndrome | 1 | 1992 | 2 |
Why?
| Postoperative Complications | 4 | 1991 | 305 |
Why?
| Myositis | 2 | 1981 | 14 |
Why?
| Glucocorticoids | 3 | 2001 | 107 |
Why?
| Adenoma | 1 | 1991 | 46 |
Why?
| Photic Stimulation | 4 | 1979 | 58 |
Why?
| Tenon Capsule | 1 | 2011 | 5 |
Why?
| Endophthalmitis | 1 | 2011 | 9 |
Why?
| Autoimmunity | 2 | 2008 | 27 |
Why?
| Binomial Distribution | 1 | 1991 | 2 |
Why?
| Prospective Studies | 4 | 1990 | 545 |
Why?
| Antigens, Thy-1 | 3 | 2003 | 22 |
Why?
| Lymphoma, B-Cell | 1 | 1992 | 33 |
Why?
| Retinal Artery | 2 | 1977 | 12 |
Why?
| Prednisone | 2 | 2008 | 80 |
Why?
| Eyelid Diseases | 1 | 1990 | 11 |
Why?
| Thiazolidinediones | 1 | 2011 | 35 |
Why?
| Coculture Techniques | 2 | 2006 | 59 |
Why?
| Acquired Immunodeficiency Syndrome | 2 | 1989 | 85 |
Why?
| Thiazoles | 1 | 2011 | 50 |
Why?
| Receptors, Prostaglandin | 1 | 2010 | 6 |
Why?
| Hypoglycemic Agents | 1 | 2011 | 44 |
Why?
| Mast Cells | 1 | 2010 | 31 |
Why?
| Delphi Technique | 1 | 2009 | 6 |
Why?
| Consensus | 1 | 2009 | 12 |
Why?
| Scotoma | 2 | 1980 | 7 |
Why?
| Endpoint Determination | 1 | 2009 | 27 |
Why?
| Transforming Growth Factor beta | 2 | 2003 | 99 |
Why?
| Migraine Disorders | 1 | 2009 | 11 |
Why?
| Fibrosis | 2 | 2005 | 46 |
Why?
| Incidence | 4 | 1997 | 336 |
Why?
| Methylmalonic Acid | 1 | 2009 | 4 |
Why?
| Radiotherapy Dosage | 1 | 2009 | 55 |
Why?
| Retinal Vasculitis | 1 | 2009 | 3 |
Why?
| Amino Acid Metabolism, Inborn Errors | 1 | 2009 | 9 |
Why?
| Propionic Acids | 1 | 2009 | 15 |
Why?
| Eosinophilia | 1 | 2009 | 24 |
Why?
| Cells, Cultured | 7 | 1994 | 447 |
Why?
| Receptors, Aryl Hydrocarbon | 1 | 2011 | 23 |
Why?
| Neurology | 1 | 2009 | 28 |
Why?
| Retina | 3 | 1970 | 60 |
Why?
| Health Care Costs | 1 | 2009 | 73 |
Why?
| Optic Atrophy | 2 | 1982 | 3 |
Why?
| Forms and Records Control | 2 | 2003 | 15 |
Why?
| Combined Modality Therapy | 2 | 1993 | 219 |
Why?
| Biomedical Research | 1 | 2009 | 87 |
Why?
| Vision, Binocular | 1 | 2007 | 13 |
Why?
| Blepharoptosis | 2 | 1983 | 8 |
Why?
| Intraoperative Care | 1 | 2007 | 34 |
Why?
| Emergency Medical Services | 1 | 2009 | 61 |
Why?
| Injections, Intravenous | 1 | 2007 | 105 |
Why?
| Suture Techniques | 1 | 2007 | 48 |
Why?
| Medical Records | 2 | 2003 | 104 |
Why?
| Cytokines | 1 | 2011 | 207 |
Why?
| Cerebrospinal Fluid Shunts | 1 | 2007 | 14 |
Why?
| Ventriculoperitoneal Shunt | 1 | 2007 | 12 |
Why?
| Patient Participation | 1 | 1997 | 40 |
Why?
| Nystagmus, Optokinetic | 2 | 1994 | 4 |
Why?
| Diabetic Retinopathy | 2 | 1984 | 14 |
Why?
| Meningeal Neoplasms | 2 | 1982 | 30 |
Why?
| Meningioma | 2 | 1982 | 26 |
Why?
| Administration, Oral | 1 | 2007 | 170 |
Why?
| Sensory Thresholds | 2 | 1994 | 25 |
Why?
| Research Design | 1 | 1998 | 169 |
Why?
| Neural Inhibition | 3 | 1980 | 30 |
Why?
| Models, Immunological | 1 | 2006 | 40 |
Why?
| Papilledema | 3 | 1982 | 3 |
Why?
| Temporal Arteries | 2 | 2001 | 6 |
Why?
| Cell Transformation, Neoplastic | 1 | 2006 | 86 |
Why?
| Lymphocyte Activation | 1 | 2006 | 137 |
Why?
| Cell Culture Techniques | 1 | 2005 | 74 |
Why?
| Retinal Detachment | 2 | 1978 | 7 |
Why?
| Constriction, Pathologic | 2 | 1991 | 65 |
Why?
| Stents | 1 | 2007 | 55 |
Why?
| Computers | 2 | 1980 | 58 |
Why?
| Veins | 2 | 1991 | 41 |
Why?
| Cell Separation | 1 | 2005 | 110 |
Why?
| Immunoenzyme Techniques | 1 | 2004 | 125 |
Why?
| Bromocriptine | 1 | 1983 | 7 |
Why?
| Time Factors | 5 | 1978 | 896 |
Why?
| Cataract | 1 | 2003 | 17 |
Why?
| Glaucoma | 1 | 2003 | 19 |
Why?
| Videotape Recording | 1 | 2003 | 45 |
Why?
| Brain Stem | 2 | 1980 | 50 |
Why?
| Syndrome | 2 | 1982 | 142 |
Why?
| Abstracting and Indexing as Topic | 1 | 2003 | 8 |
Why?
| Sensitivity and Specificity | 2 | 2003 | 427 |
Why?
| Prolactin | 1 | 1983 | 26 |
Why?
| Biopsy | 3 | 1996 | 207 |
Why?
| Body Mass Index | 1 | 2004 | 122 |
Why?
| Polyradiculoneuropathy | 1 | 1982 | 9 |
Why?
| Muscle, Smooth | 1 | 2003 | 69 |
Why?
| Myasthenia Gravis | 1 | 1982 | 18 |
Why?
| Olfaction Disorders | 1 | 1982 | 3 |
Why?
| Animals | 11 | 1970 | 1031 |
Why?
| Choroid | 1 | 1982 | 6 |
Why?
| Logistic Models | 2 | 1995 | 251 |
Why?
| Neural Conduction | 1 | 1982 | 41 |
Why?
| Pilot Projects | 1 | 2003 | 264 |
Why?
| Polychondritis, Relapsing | 1 | 2001 | 2 |
Why?
| Sex Factors | 1 | 2004 | 284 |
Why?
| Drug Therapy, Combination | 2 | 1995 | 189 |
Why?
| Reoperation | 1 | 2002 | 106 |
Why?
| Cataplexy | 1 | 1980 | 1 |
Why?
| Muscle Hypotonia | 1 | 1980 | 6 |
Why?
| Glucuronosyltransferase | 2 | 2010 | 8 |
Why?
| Acanthosis Nigricans | 1 | 2000 | 5 |
Why?
| Age Factors | 1 | 2004 | 480 |
Why?
| Glioblastoma | 1 | 1980 | 44 |
Why?
| Pedigree | 1 | 2000 | 84 |
Why?
| Predictive Value of Tests | 2 | 1991 | 321 |
Why?
| Thrombophilia | 1 | 1999 | 10 |
Why?
| California | 1 | 1999 | 40 |
Why?
| Blood Coagulation Factors | 1 | 1999 | 31 |
Why?
| Sclera | 1 | 1978 | 8 |
Why?
| Societies, Medical | 2 | 2009 | 90 |
Why?
| Family | 1 | 2000 | 101 |
Why?
| Neoplasms | 1 | 2006 | 239 |
Why?
| Inflammation | 3 | 1978 | 208 |
Why?
| Visual Perception | 1 | 1979 | 51 |
Why?
| Lung | 1 | 2005 | 232 |
Why?
| Nystagmus, Pathologic | 1 | 1977 | 9 |
Why?
| Microscopy, Fluorescence | 2 | 2005 | 137 |
Why?
| Carotid Artery Diseases | 1 | 1977 | 36 |
Why?
| Cavernous Sinus | 1 | 1996 | 4 |
Why?
| Intracranial Embolism and Thrombosis | 1 | 1996 | 8 |
Why?
| Neurons | 3 | 1978 | 195 |
Why?
| Space Perception | 1 | 1978 | 36 |
Why?
| Cell Adhesion | 2 | 2004 | 113 |
Why?
| Arteriosclerosis | 1 | 1977 | 54 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 1998 | 47 |
Why?
| Exotropia | 1 | 1996 | 3 |
Why?
| Orbit Evisceration | 1 | 1996 | 4 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 2004 | 224 |
Why?
| Fixation, Ocular | 1 | 1977 | 24 |
Why?
| Patient Selection | 2 | 1997 | 155 |
Why?
| Cyclopentolate | 1 | 1995 | 1 |
Why?
| Tinnitus | 1 | 1995 | 4 |
Why?
| Dementia | 1 | 1977 | 56 |
Why?
| Electrooculography | 2 | 1977 | 15 |
Why?
| Ophthalmic Solutions | 1 | 1995 | 12 |
Why?
| Flow Cytometry | 2 | 2005 | 216 |
Why?
| Rabbits | 2 | 1994 | 252 |
Why?
| Electronystagmography | 1 | 1994 | 5 |
Why?
| United States | 1 | 2003 | 604 |
Why?
| Accommodation, Ocular | 1 | 1994 | 5 |
Why?
| Presbyopia | 1 | 1994 | 4 |
Why?
| Carbachol | 1 | 1994 | 30 |
Why?
| Questionnaires | 1 | 1999 | 360 |
Why?
| Brain Mapping | 2 | 1970 | 61 |
Why?
| Acute Disease | 2 | 2002 | 271 |
Why?
| Diagnosis, Differential | 3 | 1978 | 402 |
Why?
| Peripheral Nervous System Neoplasms | 1 | 1993 | 8 |
Why?
| Neuropsychological Tests | 1 | 1994 | 113 |
Why?
| Remission, Spontaneous | 1 | 1992 | 32 |
Why?
| Los Angeles | 2 | 2001 | 8 |
Why?
| Disease Models, Animal | 1 | 1996 | 349 |
Why?
| Astigmatism | 1 | 1992 | 12 |
Why?
| DNA, Mitochondrial | 1 | 1992 | 32 |
Why?
| DNA Mutational Analysis | 1 | 1992 | 110 |
Why?
| Smad2 Protein | 1 | 2011 | 14 |
Why?
| Myofibroblasts | 1 | 2011 | 7 |
Why?
| Smad4 Protein | 1 | 2011 | 18 |
Why?
| Aryl Hydrocarbon Hydroxylases | 1 | 2011 | 22 |
Why?
| Phenotype | 2 | 2003 | 303 |
Why?
| Immunity, Cellular | 1 | 2011 | 85 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 1992 | 58 |
Why?
| Smad3 Protein | 1 | 2011 | 26 |
Why?
| Transforming Growth Factor beta1 | 1 | 2011 | 43 |
Why?
| Hyperthyroidism | 1 | 1990 | 18 |
Why?
| Hydantoins | 1 | 2010 | 3 |
Why?
| Gene Knockdown Techniques | 1 | 2010 | 26 |
Why?
| Tectum Mesencephali | 1 | 1970 | 1 |
Why?
| Thyroidectomy | 1 | 1990 | 21 |
Why?
| Neoplasm Staging | 1 | 1991 | 125 |
Why?
| Endocrinology | 1 | 2009 | 1 |
Why?
| Ergotamines | 1 | 2009 | 3 |
Why?
| Tryptamines | 1 | 2009 | 3 |
Why?
| Ketorolac | 1 | 2009 | 6 |
Why?
| Fibronectins | 1 | 2011 | 57 |
Why?
| Clinical Laboratory Techniques | 1 | 2009 | 31 |
Why?
| Image Processing, Computer-Assisted | 2 | 1987 | 138 |
Why?
| Antiemetics | 1 | 2009 | 15 |
Why?
| Vision, Monocular | 1 | 2009 | 8 |
Why?
| Narcotics | 1 | 2009 | 29 |
Why?
| Vasoconstriction | 1 | 2009 | 37 |
Why?
| Arterioles | 1 | 2009 | 14 |
Why?
| Blotting, Western | 1 | 2011 | 275 |
Why?
| Duane Retraction Syndrome | 1 | 1988 | 3 |
Why?
| Autoantigens | 1 | 2008 | 29 |
Why?
| Dietary Supplements | 1 | 2009 | 34 |
Why?
| Diagnostic Imaging | 1 | 2009 | 66 |
Why?
| Evoked Potentials | 3 | 1970 | 44 |
Why?
| Antiretroviral Therapy, Highly Active | 1 | 2009 | 27 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2009 | 78 |
Why?
| Patient Acceptance of Health Care | 1 | 2009 | 70 |
Why?
| Autoantibodies | 1 | 2008 | 64 |
Why?
| Research | 1 | 2009 | 124 |
Why?
| Referral and Consultation | 1 | 2009 | 134 |
Why?
| Pregnancy Complications | 1 | 1990 | 98 |
Why?
| Brain | 2 | 1980 | 305 |
Why?
| Electricity | 1 | 1987 | 14 |
Why?
| Data Interpretation, Statistical | 1 | 1998 | 109 |
Why?
| Single-Blind Method | 1 | 1997 | 86 |
Why?
| Sex Distribution | 1 | 1997 | 101 |
Why?
| Isoenzymes | 1 | 2010 | 144 |
Why?
| Protein Binding | 1 | 2010 | 256 |
Why?
| Extracellular Matrix | 1 | 2008 | 79 |
Why?
| Age Distribution | 1 | 1997 | 127 |
Why?
| Prognosis | 1 | 2000 | 388 |
Why?
| Action Potentials | 2 | 1978 | 77 |
Why?
| Reproducibility of Results | 1 | 2009 | 391 |
Why?
| Anticoagulants | 1 | 2009 | 88 |
Why?
| Outcome Assessment (Health Care) | 1 | 1998 | 163 |
Why?
| Facial Muscles | 1 | 1984 | 6 |
Why?
| Young Adult | 1 | 2009 | 380 |
Why?
| Retinal Vein | 1 | 1984 | 3 |
Why?
| DNA | 1 | 2010 | 262 |
Why?
| Magnetics | 1 | 2005 | 30 |
Why?
| Titrimetry | 1 | 2004 | 14 |
Why?
| Cell Proliferation | 1 | 2008 | 227 |
Why?
| Intraoperative Complications | 1 | 1995 | 53 |
Why?
| Quality of Life | 1 | 1998 | 188 |
Why?
| Interleukin-8 | 1 | 2004 | 54 |
Why?
| Myometrium | 1 | 2003 | 13 |
Why?
| Risk | 1 | 1984 | 203 |
Why?
| Rhode Island | 1 | 2003 | 5 |
Why?
| Baltimore | 1 | 2003 | 14 |
Why?
| RNA, Messenger | 1 | 2011 | 394 |
Why?
| Multivariate Analysis | 1 | 1995 | 225 |
Why?
| Models, Biological | 1 | 2008 | 410 |
Why?
| Peripheral Nerves | 1 | 1982 | 26 |
Why?
| Uveal Diseases | 1 | 1982 | 2 |
Why?
| Actins | 1 | 2003 | 112 |
Why?
| Frontal Lobe | 1 | 1982 | 33 |
Why?
| Synaptic Transmission | 1 | 1982 | 58 |
Why?
| Interleukin-6 | 1 | 2004 | 145 |
Why?
| Scleral Diseases | 1 | 2001 | 1 |
Why?
| Up-Regulation | 1 | 2003 | 183 |
Why?
| Exudates and Transudates | 1 | 2001 | 15 |
Why?
| Conjunctiva | 1 | 2001 | 19 |
Why?
| Interferon-gamma | 1 | 2003 | 133 |
Why?
| Narcolepsy | 1 | 1980 | 1 |
Why?
| Muscular Diseases | 1 | 1981 | 36 |
Why?
| Immunohistochemistry | 1 | 2005 | 355 |
Why?
| Blood Platelets | 1 | 2003 | 67 |
Why?
| Geniculate Bodies | 1 | 1980 | 10 |
Why?
| Hemianopsia | 1 | 1980 | 5 |
Why?
| Oculomotor Nerve | 1 | 1980 | 6 |
Why?
| Prevalence | 1 | 2002 | 281 |
Why?
| Electric Stimulation | 1 | 1980 | 101 |
Why?
| Dominance, Cerebral | 1 | 1980 | 34 |
Why?
| Intraocular Pressure | 2 | 1988 | 22 |
Why?
| Ethnic Groups | 1 | 2001 | 95 |
Why?
| Ophthalmoscopy | 1 | 1999 | 17 |
Why?
| Periodicity | 1 | 1979 | 28 |
Why?
| Cerebrovascular Disorders | 1 | 1980 | 66 |
Why?
| Choroid Neoplasms | 1 | 1978 | 5 |
Why?
| Phosphorus Radioisotopes | 1 | 1978 | 20 |
Why?
| Multiple Sclerosis | 1 | 1980 | 43 |
Why?
| Mice | 1 | 2010 | 623 |
Why?
| Embolism | 1 | 1977 | 14 |
Why?
| Carotid Artery, Internal | 1 | 1977 | 27 |
Why?
| Diagnostic Errors | 1 | 1978 | 73 |
Why?
| Caloric Tests | 1 | 1977 | 3 |
Why?
| Craniotomy | 1 | 1996 | 15 |
Why?
| Memory Disorders | 1 | 1977 | 29 |
Why?
| Cerebellum | 1 | 1977 | 59 |
Why?
| Melanoma | 1 | 1978 | 87 |
Why?
| Terminology as Topic | 1 | 1977 | 81 |
Why?
| Ultrasonography | 1 | 1978 | 89 |
Why?
| Pain | 1 | 1978 | 191 |
Why?
| Secretory Rate | 1 | 1994 | 20 |
Why?
| Alkalies | 1 | 1994 | 8 |
Why?
| Endocytosis | 1 | 1994 | 38 |
Why?
| Sodium-Hydrogen Antiporter | 1 | 1994 | 18 |
Why?
| Eye Proteins | 1 | 1994 | 26 |
Why?
| Cytoplasm | 1 | 1994 | 108 |
Why?
| Light | 1 | 1970 | 64 |
Why?
| Iris Diseases | 1 | 1988 | 5 |
Why?
| Reaction Time | 1 | 1988 | 81 |
Why?
| Hypertension | 1 | 1988 | 161 |
Why?
| Pregnancy | 1 | 1990 | 455 |
Why?
|
|
Feldon's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
